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IMPORTANCE Early-life exposures, such as prenatal maternal lifestyle, illnesses, nutritional
deficiencies, toxin levels, and adverse birth events, have long been considered potential risk
factors for neurodevelopmental disorders in offspring. However, maternal genetic factors
could be confounding the association between early-life exposures and neurodevelopmental
outcomes in offspring, whichmakes inferring a causal relationship problematic.
OBJECTIVE To test whether maternal polygenic risk scores (PRSs) for neurodevelopmental
disorders were associated with early-life exposures previously linked to the disorders.
DESIGN, SETTING, AND PARTICIPANTS In this UK population-based cohort study, 7921mothers
with genotype data from the Avon Longitudinal Study of Parents and Children (ALSPAC)
underwent testing for association of maternal PRS for attention-deficit/hyperactivity disorder
(ADHD PRS), autism spectrum disorder (ASD PRS), and schizophrenia (SCZ PRS) with 32
early-life exposures. ALSPAC data collection began September 6, 1990, and is ongoing. Data
were analyzed for the current study from April 1 to September 1, 2018.
EXPOSURES Maternal ADHD PRS, ASD PRS, and SCZ PRS were calculated using discovery
effect size estimates from the largest available genome-wide association study and a
significance threshold of P < .05.
MAIN OUTCOMES ANDMEASURES Outcomesmeasured included questionnaire data on
maternal lifestyle and behavior (eg, smoking, alcohol consumption, bodymass index, and
maternal age), maternal use of nutritional supplements andmedications in pregnancy (eg,
acetaminophen, iron, zinc, folic acid, and vitamins), maternal illnesses (eg, diabetes,
hypertension, rheumatism, psoriasis, and depression), and perinatal factors (eg, birth weight,
preterm birth, and cesarean delivery).
RESULTS Maternal PRSs were available from 7921 mothers (mean [SD] age, 28.5 [4.8] years).
The ADHD PRS was associated with multiple prenatal factors, including infections (odds ratio
[OR], 1.11; 95% CI, 1.04-1.18), use of acetaminophen during late pregnancy (OR, 1.11; 95% CI,
1.04-1.18), lower blood levels of mercury (β coefficient, −0.06; 95% CI, −0.11 to −0.02), and
higher blood levels of cadmium (β coefficient, 0.07; 95% CI, 0.05-0.09). Little evidence of
associations between ASD PRS or SCZ PRS and prenatal factors or of association between any
of the PRSs and adverse birth events was found. Sensitivity analyses revealed consistent
results.
CONCLUSIONS AND RELEVANCE These findings suggest that maternal risk alleles for
neurodevelopmental disorders, primarily ADHD, are associated with some pregnancy-related
exposures. These findings highlight the need to carefully account for potential genetic
confounding and triangulate evidence from different approaches when assessing the effects
of prenatal exposures on neurodevelopmental disorders in offspring.
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N eurodevelopmental disorders involve atypical braindevelopment affecting domains such as language,motor skills, social communication, attention, activ-
ity regulation, and learning.1 This group of disorders includes
attention-deficit/hyperactivity disorder (ADHD) and autism
spectrum disorder (ASD) and is sometimes broadened to
encompass schizophrenia (SCZ) because its onset is often
preceded byneurodevelopmental impairments. Neurodevel-
opmental disorders are highly heritable (60%-90%),2,3
although they are associated with a combination of multiple
genetic, environmental, and stochastic factors.4
Prenatal and perinatal exposures to adversities have long
been considered to be possible risk factors for neurodevelop-
mental disorders and are biologically plausible as causal
risks because they occur during a sensitive time in
neurodevelopment.5 Prenatal factors linkedwith neurodevel-
opmental disorders include smoking,6-8 alcohol intake,9nutri-
tional deficiencies (eg, vitaminD),7 poor nutrition,10,11 nonuse
of nutritional supplements (eg, folic acid),medication use (eg,
acetaminophen [paracetamol], antidepressants),12-14 prepreg-
nancy body mass index (BMI) (calculated as weight in kilo-
gramsdividedbyheight inmeters squared),15 ageatdelivery,16
metabolic disorders (eg, diabetes, preeclampsia),17 immune-
related conditions (eg, infection, autoimmune diseases),18,19
depression,10,11 stressful lifeevents,9,20andtoxin levels (eg,mer-
cury, lead).21,22 Adverse perinatal factors (eg, lowbirthweight,
prematurity, cesarean delivery) have been shown to be associ-
ated with all 3 neurodevelopmental disorders.23-25 However,
with someexceptions,10,11most of these studieswereobserva-
tionalandarethereforenotappropriateforassessingcausality.26
Confounding by sometimes unknown lifestyle, socioeco-
nomic, or genetic factors can lead to apparent associationsbe-
tweenearly-life factorsandneurodevelopmentaloutcomesthat
arenotcausal.Potential genetic confounding isparticularly im-
portant for factors such asmaternal smoking,which is known
tobeassociatedwithmaternalgenotype.27,28Other factorssuch
as birth weight are associated with maternal and fetal
genotypes.29 If genetic factors are independently associated
with neurodevelopmental disorders and early-life exposures
(horizontal pleiotropy), then associations could arise for non-
causal reasons.For example, of 12 studiesusingdifferent caus-
ally informativedesigns, suchasdiscordant siblingpairs,30ma-
ternalvspaternal exposures,31 anassistedconceptioncohort,32
and children of twins,33 11 showed that maternal smoking in
pregnancy does not appear to have a causal effect on ADHD,
although it has an effect on lowering birth weight.34 How-
ever, suchdesignshavenot been able to address the full range
of prenatal and perinatal risks.
Genome-wide association studies (GWAS) suggest that
genetic liability toneurodevelopmentaldisorders is inpart con-
ferred by a large number of common (present in >1% of the
population) single-nucleotide polymorphisms (SNPs).35-37
TheseSNPscanbeused togeneratecompositemeasures called
polygenic risk scores (PRSs),38 which have been shown to be
associated with a range of phenotypes in the general popula-
tion for neurodevelopmental disorders.39,40 In this study, we
used a large population-based pregnancy cohort from the
UnitedKingdomto investigatewhetherPRSs forADHD(ADHD
PRS), ASD (ASD PRS), and schizophrenia (SCZ PRS) are asso-
ciatedwithearly-life exposures linked to thesedisorders.9,20,41
Methods
Avon Longitudinal Study of Parents and Children Study Data
The ongoing prospective Avon Longitudinal Study of Parents
andChildren(ALSPAC)initiallyrecruited14541pregnantwomen
living in Avon, United Kingdom, with expected delivery dates
fromApril 1991 toDecember1992andwith13988childrenalive
at year 1. Of those, 10015 mothers and 9912 children under-
went genotyping using 2 platforms (Human660W-quad and
HumanHap550-quad [Illumina], respectively). After standard
quality control, the resulting data set included 7921 unrelated
mothers and 7975 unrelated children of European ancestry.
Detailed procedures for quality control have been published
previously.42 Detailed information on the health and lifestyles
ofmothers andchildrenwascollected fromregular clinical vis-
its and self-administrated questionnaires. A detailed descrip-
tionof thecohorthasbeenpublishedpreviously.43,44Thestudy
website contains a fully searchable data dictionary and vari-
able search tool.45 Ethical approval for the studywas obtained
from the ALSPAC Ethics and Law Committee and the local re-
search ethics committees.46 All participants provided written
informedconsent.ALSPACdata collectionbeganSeptember6,
1990, and is ongoing.Datawere analyzed for the current study
fromApril 1 to September 1, 2018.
Polygenic Risk Score
Polygenic risk scoreswerecalculatedusingPRSice,version1.25
(Statistical Genetics Unit, King’s College London) and PLINK,
version 1.9,47 as the weighted mean number of disorder risk
alleles in approximate linkage equilibrium (R2 < 0.1 within
1000-kilobasedistance), asdescribedpreviously.48Riskalleles
forADHDandASDweredefinedas those identified in themost
recent combined Psychiatric Genomics Consortium and
Lundbeck Foundation Initiative for Integrative Psychiatric
Research (iPSYCH) analysis of case-control GWAS35,36 at a sig-
nificance threshold of P < .05 to maximize phenotypic vari-
ance. Risk alleles for schizophrenia were identified by the
Key Points
Question Arematernalpolygenic riskscores forneurodevelopmental
disorders associatedwith early-life exposures?
Findings In this population-based cohort study of 7921 mothers,
polygenic risk score for attention-deficit/hyperactivity disorder
was associated with a range of early-life exposures linked to
neurodevelopmental disorders in offspring. Polygenic risk scores
for autism spectrum disorder and schizophrenia showed little
evidence association with of early-life exposures.
Meaning The findings suggest that mothers at high genetic risk
for attention-deficit/hyperactivity disorder may also be at
increased risk for some adverse pregnancy exposures, and future
studies should triangulate evidence from different causally
informative approaches.
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Psychiatric Genomics Consortium meta-analysis.37 For
sensitivity analysis, PRSs were derived using various
P values. The number of SNPs included for each threshold
and correlations among PRSs are provided in eTables 1 and 2
in the Supplement.
OutcomeMeasures
Prenatal Factors Related toMaternal Lifestyle
Maternal smoking and alcohol consumption were assessed
by self-report during the first and third trimesters; thepartici-
pants were asked whether they had smoked or consumed
alcohol in the past 3months. The 2measurements were used
to classify smoking and alcohol consumption during preg-
nancy as any time vs never. Binge drinking was defined as
havingconsumed theequivalentofmore than4drinksperday
at least once during the past 4 weeks.49 Maternal BMI was
derived from self-reported prepregnancy height and weight.
Maternal age was obtained at recruitment.
Maternal Use of Nutritional Supplements
andMedications in Pregnancy
The use of antidepressants and the intake of iron, zinc, folic
acid,orvitaminsupplementswerecategorizedasnevervsever
based onmaternal report in the first and third trimesters. Use
of acetaminophenwasmaternally reported for the first (week
18) and the second (week 32) halves of pregnancy.
Maternal Illnesses and Conditions
Stressful life events scores were calculated based onmaternal
report of whether participants had experienced 18 different
stressful life eventsduring the first and third trimestersof their
pregnancy.50 Severedepression,diabetes,hypertension, rheu-
matism, and psoriasis were categorized as ever vs never expe-
rienced. In addition, mothers were asked if they experienced
preeclampsia, infections, or bleeding during pregnancy.
Biomarkers of Nutritional Status and Toxin Exposure in Pregnancy
Blood levels of vitamin D (25-hydroxyvitamin D), selenium,
mercury, cadmium,and leadweremeasured inmaternalblood
samples during pregnancy, as described elsewhere.51,52 All of
these measures were log-transformed.
Perinatal Factors and Conditions
Adverse birth events included low birth weight, preterm de-
livery, cesarean delivery, hypoxia, and Apgar scores at 1 and 5
minutes after birth, and were obtained from obstetric rec-
ords. Low birth weight was defined as less than 2500 g;
preterm delivery, born before 37weeks’ gestation. The Apgar
score was dichotomized as healthy when 7 or greater and
adverse when less than 7.53 Mothers were asked if they initi-
ated breastfeeding their child in the first month after birth.
Statistical Analysis
Datawere analyzed fromApril 1 to September 1, 2018.Associa-
tionsofearly-lifeexposureswithmaternalADHDPRS,ASDPRS,
or SCZ PRSwere assessed using general linearmodels for con-
tinuous outcomes and general linear models with logit-link
function andPoissondistribution for binary outcomes in Stata
software, version 15.1 (StataCorp). Ten population stratifica-
tionprincipal components derived fromunrelated individuals
using the Eigenstrat method54 were included as covariates in
all analyses. In addition, the perinatal factors were tested for
association with child ADHD PRS, ASD PRS, and SCZ PRS after
adjusting for sexand 10principal componentsbecauseperina-
tal factors canbeassociatedwithmaternalor childgenetic risk.
Effect estimates are presented per 1-SD increase in PRS.
To correct for multiple testing of 32 early-life exposures,
thenumberof independent testswasdeterminedbasedon the
number of principal components that explained 80% of co-
variance between the early-life exposures in a principal com-
ponent analysis (eMethods and eTable 3 in the Supplement).
Weconcluded that21 independent testswereperformed, lead-
ing to a multiple testing–corrected P < .0024 (.05/21), which
is slightly less conservative than the Bonferroni-corrected
P < .0016 (.05/32) (assuming that all tests are independent).
Asasensitivityanalysis,weperformedan inverseprobabil-
ityweightingonmissingmaternalgeneticdata (eMethods inthe
Supplement) becauseADHDPRS and SCZ PRSwere associated
with attrition in the ALSPAC core study.55 A comparison be-
tweenthestudysampleswith(n = 7486)andwithout (n = 6307)
genetic data suggests that the groupsdiffer in someof the ana-
lyzed factors (eMethods and eTable 4 in the Supplement).
Results
Associations Between PRSs and Early-Life Exposures
Factors AssociatedWithMaternal Lifestyle
Descriptive characteristics of the sample are presented in
Table 1.Mean (SD) ageofmothers of theALSPACstudy sample
was28.5 (4.8) years;mean (SD)BMI, 22.9 (3.8).Maternal PRSs
for neurodevelopmental disorders showed evidence of asso-
ciations with smoking (ADHD PRS and SCZ PRS), use of acet-
aminophen (ADHD PRS), prepregnancy BMI (ADHD PRS and
SCZ PRS), and age at delivery (ADHD PRS) (Table 2). A 1-SD
increase in maternal ADHD PRS was associated with a 27%
increase of smoking during pregnancy (odds ratio [OR], 1.27;
95% CI, 1.19-1.35); a 1-SD increase in maternal SCZ PRS, with
an 11% increase of smoking during pregnancy (OR, 1.11; 95%
CI, 1.04-1.18).MaternalADHDPRSwasassociatedwithyounger
maternal age at delivery (β coefficient, −0.42; 95% CI, 0.53-
0.31) (similar resultswere found for associationsbetweenPRSs
andcategoricallydefinedagegroups in eTable 5 in theSupple-
ment). Association with maternal prepregnancy BMI oc-
curred inoppositedirections forADHDPRS (βcoefficient,0.27;
95% CI, 0.18-0.36) and SCZ PRS (β coefficient, −0.16; 95% CI,
−0.26 to−0.07). Examiningassociations atdifferent times,we
found evidence of an association betweenADHDPRS anduse
of acetaminophen during the second half of pregnancy, such
that a 1-SD increase in ADHD PRS was associated with an
11% increase in the odds of taking acetaminophen (OR, 1.11;
95% CI, 1.04-1.18).
Maternal Illnesses and Conditions
Wefoundevidenceofassociationsbetweenall 3maternalPRSs
andahigher riskof experiencing severedepression (OR range,
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1.12 [95% CI, 1.02-1.23] to 1.21 [95% CI, 1.11-1.33]) and an in-
creased stressful life events score in the first trimester of preg-
nancy (βcoefficient range,0.11 [95%CI,0.05-0.17] to0.13 [95%
CI, 0.07-0.19]) (Table 3). In addition, ADHD PRS showed evi-
dence of an associationwith infection during pregnancy (OR,
1.11; 95%CI, 1.04-1.18). Little evidencewas found for associa-
tions with other illnesses or conditions.
Biomarkers of Nutritional Status and Toxin Exposure in Pregnancy
MaternalADHDPRSshowedevidenceofassociationwith lower
selenium levels (β coefficient, −0.01; 95%CI, −0.02 to 0.005)
andhigher cadmium levels (β coefficient, 0.07; 95%CI, 0.05-
0.0009). In addition, ADHDPRS showed evidence of associa-
tionswith lowermercury levels (β coefficient, −0.06; 95%CI,
−0.11 to −0.02), but little evidence of association with vita-
minDor lead (Table 4). Little evidencewas found for associa-
tions betweenmaternal ASD PRS and SCZ PRS and any of the
biomarkers.
Perinatal Factors and Conditions
We found little evidence of an association between maternal
neurodevelopmental riskscoresandbirthevents, including low
birth weight, preterm delivery, cesarean delivery, and hy-
poxia (Table 5). Furthermore, therewasno strong evidence of
associations between these outcomes and child neurodevel-
opmental PRSs (Table 5).
Sensitivity Analyses
Sensitivity analysis revealedconsistent results acrossdifferent
P value thresholds for all 3 PRSs, as shown in eFigures 1 to 6 in
theSupplement.Toaccount forattrition,weperformed inverse
probabilityweighting on availability of genetic data and reran
ourmain analysis with the derivedweights, which revealed a
similar pattern of results (eTables 6 and 7 in the Supplement).
In addition,weevaluated theobservational associationof
the investigated early-life exposures with ADHD and ASD
symptomsinchildren intheALSPACpopulation (eMethodsand
eTable 8 in the Supplement). We found evidence of an asso-
ciation of smoking (relative risk [RR], 1.70; 95% CI, 1.37-2.10)
anduse of acetaminophen (RR, 1.45; 95%CI, 1.18-1.78) during
pregnancy, ever having depression (RR, 1.64; 95% CI, 1.20-
2.25), andan increasedstressful life events score (RR, 1.15;95%
CI, 1.10-1.20)withan increased riskofADHD, asdescribedpre-
viously for this cohort.14,31
Discussion
Thepresent studyexamines theassociationbetweenneurode-
velopmental disorder PRSs and early-life exposures associ-
atedwith those disorders.We found thatmaternal risk alleles
for neurodevelopmental disorders, primarily ADHD,were as-
sociatedwith someprenatal factors. These findings are in line
with those of studies showing substantial associations be-
tween genetic factors and environmental experiences56 and
highlight theneed to account for genetic confounding in stud-
ies of pregnancy-related exposures and neurodevelopmental
disorders.
Table 1. Sample Description
Exposure
Total No. of
Participants
Participants
With Exposure
Smoking, No. (%)
During first trimester 7330 1620 (22.1)
During third trimester 6787 1157 (17.0)
Alcohol consumption, No. (%)
During first trimester 7276 4051 (55.7)
During third trimester 4355 1526 (35.0)
Binge drinking during
first trimester, No. (%)
7263 1181 (16.3)
Any nutritional supplements
in pregnancy, No. (%)
Iron 7270 1541 (21.2)
Zinc 7270 92 (1.3)
Folic acid 7263 688 (9.5)
Vitamins 7253 1190 (16.4)
Acetaminophen, No. (%)
Early pregnancy 7142 3838 (53.7)
Late pregnancy 6748 2888 (42.8)
Any antidepressants in pregnancy, No. (%) 7153 58 (0.8)
Maternal illnesses and conditions
Prepregnancy BMI,
mean (SD) [range]
6516 22.9 (3.8)
[12.5-51.2]
Age at delivery,
mean (SD) [range], y
7486 28.5 (4.8)
[15-44]
Ever had diabetes, No. (%) 6913 71 (1.0)
Gestational diabetes, No. (%) 7412 68 (0.9)
Ever had hypertension, No. (%) 6806 984 (14.5)
Gestational hypertension, No. (%) 7252 1058 (14.6)
Preeclampsia, No. (%) 7412 160 (2.2)
Any vaginal bleeding in pregnancy, No. (%) 6759 1198 (17.7)
Any infection in pregnancy, No. (%) 6683 1476 (22.1)
Ever had rheumatism, No. (%) 6817 295 (4.3)
Ever had psoriasis, No. (%) 6793 256 (3.8)
Ever had severe depression, No. (%) 6847 539 (7.9)
Stressful life event score, mean (SD) [range]
First trimester 6841 3.6 (2.6) [0-18]
Third trimester 6695 3.5 (2.4) [0-26]
Pregnancy blood levels, mean (SD), [range]
Vitamin D, pg/mL 4793 67.6 (32.1)
[8.6-248.1]
Selenium, μg/L 2625 112.4 (24.0)
[17.0-319.4]
Hemoglobin, g/dL 2535 2.1 (1.1)
[0.3-11.5]
Cadmium, μg/L 2624 0.5 (0.6)
[0.1-4.6]
Lead, μg/dL 2624 3.6 (1.5)
[0.2-19.1]
Cesarean delivery, No. (%) 6660 674 (10.1)
Low birth weight (<2500 g), No. (%) 7387 328 (4.4)
Preterm delivery (<37wk), No. (%) 7486 399 (5.3)
Hypoxia, No. (%) 4405 1301 (29.5)
Low Apgar score, No. (%)
At 1min 4387 539 (12.3)
At 5min 4383 49 (1.1)
Breastfeeding at 1mo, No. (%) 6490 5053 (77.9)
Abbreviation: BMI, bodymass index (calculated as weight in kilograms divided
by height in meters squared).
SI conversion factors: To convert cadmium to nanomoles per liter, multiply by
8.896; hemoglobin to grams per liter, multiply by 10.0; lead tomicromoles per
liter, multiply by 0.0483; selenium tomicromoles per liter, multiply by 0.0127;
vitamin D to picomoles per liter, multiply by 2.496.
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Onlymaternal stressful life events during pregnancy and
lifetime depression showed consistent associations with PRS
for all 3neurodevelopmental disorders. Theseassociations are
in line with previous findings suggesting that some stressful
life events are heritable57 and that stressful life events, de-
pression, and neurodevelopmental disorders share genetic
risk factors.58,59 Apart fromhorizontal pleiotropy, a potential
explanation for the PRS associationswith stressful life events
is thatmaternal traits of neurodevelopmental disorders could
beassociatedwith stressful situations,makingmothers athigh
genetic risk forADHDmore likely toencounter stressfulevents.
MaternalADHDPRS showedassociationswith avariety of
prenatal factors. Consistent with previous studies, we found
that genetic liability forADHDwasassociatedwithhigherBMI,
youngermaternalageatdelivery,andsmoking.35Toourknowl-
edge, this studywas the first to report that genetic liability to
Table 2. Associations ofMaternal PRSs for ADHD, ASD, and SchizophreniaWith Lifestyle-Related Prenatal Exposures
Variable
ADHD PRS ASD PRS SCZ PRS
OR or β Coefficient
(95% CI)a P Value
OR or β Coefficient
(95% CI)a P Value
OR or β Coefficient
(95% CI)a P Value
Smoking, OR
During first trimester 1.25 (1.17 to 1.33) 1 × 10−11 1.04 (0.98 to 1.11) .18 1.14 (1.04 to 1.18) .001
During third trimester 1.27 (1.18 to 1.36) 6 × 10−11 1.06 (0.99 to 1.14) .09 1.06 (0.99 to 1.14) .08
Alcohol consumption, OR
During first trimester 0.99 (0.92 to 1.06) .76 1.00 (0.94 to 1.08) .91 1.01 (0.94 to 1.08) .85
During third trimester 0.91 (0.84 to 0.98) .02 1.05 (0.97 to 1.13) .22 1.05 (0.97 to 1.13) .26
Binge drinking during first
trimester
1.11 (1.03 to 1.18) .004 1.05 (0.98 to 1.13) .15 1.08 (1.01 to 1.16) .02
Taking supplements during
pregnancy, OR
Iron 0.97 (0.91 to 1.03) .31 1.00 (0.94 to 1.06) .92 1.09 (1.02 to 1.16) .01
Zinc 0.91 (0.74 to 1.13) .40 0.98 (0.79 to 1.20) .82 1.22 (0.99 to 1.50) .06
Folic acid 0.96 (0.89 to 1.05) .36 1.06 (0.98 to 1.15) .17 1.11 (1.03 to 1.21) .01
Vitamins 0.94 (0.88 to 1.01) .09 0.99 (0.92 to 1.06) .73 1.10 (1.03 to 1.18) .005
Use of acetaminophen, OR
In early pregnancy 1.09 (1.02 to 1.17) .01 1.00 (0.94 to 1.08) .93 0.97 (0.90 to 1.03) .32
In late pregnancy 1.11 (1.04 to 1.18) .002 0.99 (0.93 to 1.05) .68 1.02 (0.95 to 1.08) .62
Use of antidepressants, OR 1.06 (0.82 to 1.38) .64 1.05 (0.81 to 1.36) .70 1.02 (0.78 to 1.32) .90
Prepregnancy BMI, β coefficient 0.27 (0.18 to 0.36) 8 × 10−9 −0.02 (−0.11 to 0.07) .70 −0.16 (−0.26 to −0.07) .001
Age at delivery, β coefficient −0.42 (−0.53 to −0.31) 2 × 10−14 0.09 (−0.01 to 0.20) .095 0.05 (−0.06 to 0.16) .35
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder; BMI, bodymass index (calculated as weight in kilograms
divided by height in meters squared); OR, odds ratio; PRS, polygenic risk score; SCZ, schizophrenia.
a Odds ratios were calculated for binary outcomes; β coefficients, for continuous outcomes.
Table 3. Associations ofMaternal PRSs for ADHD, ASD, and SchizophreniaWithMaternal Illnesses and Conditions
Variable
ADHD PRS ASD PRS SCZ PRS
OR or β Coefficient
(95% CI)a P Value
OR or β Coefficient
(95% CI)a P Value
OR or β Coefficient
(95% CI)a P Value
Ever had diabetes, OR 1.30 (1.03 to 1.65) .03 1.13 (0.89 to 1.43) .31 1.01 (0.79 to 1.28) .97
Gestational diabetes, OR 1.32 (1.03 to 1.67) .03 1.04 (0.82 to 1.32) .75 0.89 (0.70 to 1.13) .33
Ever had hypertension, OR 1.06 (0.98 to 1.14) .13 1.01 (0.94 to 1.09) .74 1.07 (0.99 to 1.15) .08
Gestational hypertension, OR 0.96 (0.90 to 1.03) .27 0.99 (0.92 to 1.06) .746 1.05 (0.97 to 1.12) .21
Preeclampsia, OR 1.09 (0.93 to 1.28) .30 1.18 (1.01 to 1.39) .04 1.08 (0.92 to 1.26) .37
Vaginal bleeding in pregnancy, OR 1.03 (0.96 to 1.10) .47 1.01 (0.94 to 1.08) .80 1.08 (1.00 to 1.15) .04
Any infection in pregnancy, OR 1.11 (1.04 to 1.18) .002 1.06 (0.99 to 1.13) .09 1.03 (0.97 to 1.10) .33
Ever had rheumatism, OR 1.05 (0.93 to 1.19) .40 1.16 (1.03 to 1.31) .02 1.03 (0.91 to 1.16) .63
Ever had psoriasis, OR 1.00 (0.88 to 1.13) .97 1.04 (0.92 to 1.18) .53 1.04 (0.91 to 1.18) .55
Ever had severe depression, OR 1.21 (1.11 to 1.33) 4 × 10−5 1.12 (1.02 to 1.23) .01 1.21 (1.11 to 1.33) 5 × 10−5
Stressful life event score,
β coefficient
First trimester 0.13 (0.07 to 0.19) 4 × 10−5 0.11 (0.05 to 0.17) 3 × 10−4 0.12 (0.06 to 0.18) 2 × 10−4
Third trimester 0.08 (0.02 to 0.14) .008 0.09 (0.004 to 0.03) .004 0.05 (−0.01 to 0.11) .09
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder; OR, odds ratio; PRS, polygenic risk score; SCZ, schizophrenia.
a Odds ratios were calculated for binary outcomes; β coefficients, for continuous outcomes.
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ADHD may also be associated with infections, acetamino-
phen use, and blood levels of toxins in pregnant mothers.
Acetaminophenexposure inpregnancy is of considerable cur-
rent interest because studies have raised concern about its
safety owing to the observed association with offspring
ADHD.60 Our results suggest thatmothers with higher ADHD
PRS may also be more likely to use acetaminophen in preg-
nancy.Whether theassociationbetweenADHDandacetamino-
phen use holds after adjusting for shared genetic factors and
represents a causal relationship should be assessed in a caus-
ally informativemendelianrandomizationframeworkandwith
other genetically informativedesigns that test andaccount for
horizontal pleiotropy.61,62
The association betweenADHDPRS and lower biomarker
levels of selenium and mercury may seem counterintuitive.
However, because fish is a major source of these heavy met-
als in the general population andADHD is associatedwith low
fish consumption,63 a possible explanation could be that
mothers with higher ADHD PRS consumed less fish.
In contrast to ADHD PRS, we found little evidence of
associations between ASD PRS or SCZ PRS and early-life
factors (except for SCZ PRS with lower BMI and more smok-
ing, consistent with previous studies). It is possible that
ADHD risk alleles have especially widespread pleiotropic or
causal effects on lifestyle and risk-taking behavior during
pregnancy. In addition, the differential pattern of associa-
tions could be driven in part by genetic overlap between the
3 disorders and educational attainment. Although ADHD
has shown genetic overlap with lower educational
attainment,35 genetic overlap with higher educational
attainment has been found for ASD and less strongly for
schizophrenia.59,64 Educational attainment has been shown
to be associated with health-conscious behavior65 and
pregnancy-related exposures.66 The differential associa-
tions with educational attainment might also explain why
many of the coefficients for ASD PRS and SCZ PRS were in
the opposite direction from ADHD PRS (eg, age at childbirth,
selenium levels, folic acid intake, and breastfeeding).
Future studies could use a multipolygenic score model to
assess the extent to which associations between neuro-
developmental disorder risk alleles and prenatal factors may
be explained by education-associated alleles.67
Table4.AssociationsofMaternalPRSs forADHD,ASD, andSchizophreniaWithMaternalBloodBiomarkersofNutritional StatusandToxins inPregnancy
Biomarker
ADHD PRS ASD PRS SCZ PRS
β Coefficient (95% CI) P Value β Coefficient (95% CI) P Value β Coefficient (95% CI) P Value
Vitamin Da 0.01 (−0.003 to 0.02) .99 −0.01 (−0.02 to 0.01) .24 0.01 (−0.003 to 0.02) .12
Selenium −0.01 (−0.02 to 0.00) .001 0.001 (−0.01 to 0.01) .84 0.004 (−0.004 to 0.01) .30
Mercury −0.06 (−0.11 to −0.02) .003 0.02 (−0.02 to 0.06) .42 0.03 (−0.02 to 0.07) .24
Cadmium 0.07 (0.05 to 0.09) 1 × 10−9 0.01 (−0.01 to 0.03 .52 0.03 (0.004 to 0.05) .02
Lead −0.03 (−0.08 to 0.03) .36 0.03 (−0.03 to 0.08) .36 −0.01 (−0.07 to 0.04) .63
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder; PRS, polygenic risk score; SCZ, schizophrenia.
a Indicates log transformed.
Table 5. Associations ofMaternal and Child PRSs for ADHD, ASD, and SchizophreniaWith Perinatal Exposures and Conditions
Exposure
No. of Participants ADHD PRS ASD PRS SCZ PRS
No Yes Total OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value
Associations With Maternal PRSs
Cesarean delivery 5986 674 6660 0.99 (0.91-1.08) .80 1.03 (0.95-1.12) .47 0.95 (0.87-1.03) .20
Low birth weight, <2500 g 7059 328 7387 1.08 (0.97-1.21) .18 1.00 (0.90-1.13) .94 1.02 (0.62-1.68) .94
Preterm delivery, <37 wk 7087 399 7486 0.99 (0.89-1.10) .85 0.96 (0.87-1.07) .49 0.96 (0.87-1.07) .46
Hypoxia 3104 1301 4405 1.05 (0.97-1.14) .20 1.04 (0.97-1.13) .28 1.02 (0.95-1.11) .56
Low Apgar score
At 1 min 3848 539 4387 1.11 (1.01-1.23) .03 1.02 (0.93-1.13) .65 1.00 (0.91-1.11) .95
At 5 min 4334 49 4383 1.05 (0.79-1.39) .74 1.04 (0.79-1.38) .78 0.77 (0.57-1.03) .07
Breastfeeding at 1 mo 1437 5053 6490 0.88 (0.78-0.99) .04 1.05 (0.92-1.19) .47 1.02 (0.90-1.16) .75
Associations With Child PRSs
Cesarean delivery 6126 686 6812 0.98 (0.90-1.07) .62 0.97 (0.89-1.05) .45 1.00 (0.92-1.08) .92
Low birth weight, 2500 g 7118 298 7416 1.06 (0.94-1.19) .36 0.97 (0.86-1.09) .63 0.96 (0.85-1.09) .54
Preterm delivery, <37 wk 7134 374 7508 1.03 (0.92-1.15) .62 0.94 (0.85-1.05) .30 0.95 (0.85-1.06) .37
Hypoxia 3147 1256 4403 0.97 (0.90-1.05) .52 0.99 (0.91-1.07) .74 0.98 (0.91-1.06) .66
Low Apgar score
At 1 min 3886 511 4397 1.01 (1.00-1.01) .27 1.00 (0.99-1.01) .69 1.00 (0.99-1.01) .45
At 5 min 4348 47 4395 1.00 (1.00-1.01) .13 1.00 (1.00-1.00) .44 1.00 (1.00-1.00) .56
Breastfeeding at 1 mo 1351 5701 7052 0.89 (0.78-1.02) .10 1.06 (0.93-1.22) .39 1.04 (0.91-1.19) .60
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder; OR, odds ratio; PRS, polygenic risk score; SCZ, schizophrenia.
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Our results have implications for supporting pregnant
women with neurodevelopmental problems such as ADHD,
given thatmaternal neurodevelopmental risk alleleswere as-
sociated with exposure to adverse conditions (eg, stress) and
risky behaviors (eg, smoking) in pregnancy. The associations
betweenADHDPRS andprenatal exposureswere generally of
small magnitude, and additional types of investigations are
needed to assess whether the associations are of clinical im-
portance.Nevertheless, our findings add to the increasingevi-
dence that the observational associations betweenmanypre-
natal factors and neurodevelopmental disorders in offspring
maybeat least partially genetically confounded.However, the
presenceof genetic confoundingdoesnot exclude a causal ef-
fect. Genetic effects may even be mediated through an envi-
ronmental exposure. For example, in the present study, we
foundthatmaternalADHDPRSwasassociatedwithhigher lev-
els of the heavymetal cadmium, for which smoking is a com-
mon source.68 Although maternal genetic liability for ADHD
predisposesmothers to smokeduringpregnancy,prenatal cad-
mium exposure due to smoking could still be associatedwith
an increased risk for ADHD in offspring. However, this in-
creased risk has been shown to beunlikely by triangulation of
evidence from studies comparing smoking during pregnancy
between mothers and fathers and between genetically re-
latedandunrelatedmothers (invitro fertilization cohort).34,44
Disentangling complex questions ofwhether prenatal factors
causally influence riskofneurodevelopmentaldisorders inoff-
spring will likely require such triangulation of evidence from
multiple approaches that rely on different assumptions and
have unrelated sources of potential biases,69,70 including
genetically informedmethods.62
Limitations
ALSPACdidnotassessdiagnosisofmaternalADHDorASD,and
only 7mothers reportedadiagnosis of SCZ; therefore,wewere
not able to evaluate the estimation of our generated PRSs or
test for the association of observed maternal neurodevelop-
mental traits with early-life exposures in ALSPAC. Neverthe-
less, previous studies of children in the ALSPAC population
have found robust associationsbetweenADHDPRSandADHD
symptoms,71 associations between ASD PRS and ASD
symptoms,71 and associations between SCZ PRS and negative
symptoms of SCZ.39
Polygenic risk scores have been demonstrated to be use-
ful instruments for polygenic traits commonly used to inves-
tigate the genetic architecture of many disorders.40 How-
ever, PRSs currently explain only a small amount of variance
in heritability of neurodevelopmental disorders.35,36,72 Our
power to detect associations with exposures may have been
low for ASD because its SNP heritability is lower than that for
ADHD and SCZ.73
GiventhatADHDPRS(aswell asSCZPRS) isassociatedwith
study attrition,74 we performed inverse probability weight-
ing sensitivity analyses accounting for the probability of hav-
ing genetic data available. The weighted analyses showed
similar results. Nevertheless, given that not all selection-
associated factors couldbe included in theweighting,biasmay
remain. Furthermore, sample sizeswere small for someearly-
life exposures, and the nested studies for heavymetal detec-
tion in pregnancy might be limited by selection bias. Al-
though we have accounted for multiple testing, we must
acknowledge that some of our findings might still occur by
chance. Our study relied on self-reported smoking and alco-
hol consumption. These exposures may be underreported,
especially during pregnancy,when smoking and alcohol con-
sumption is considered socially undesirable, but resultswere
consistent when comparing self-reported smoking and alco-
hol consumption before pregnancy (eTable 9 in the Supple-
ment). We also did not have information about maternal use
of medication to treat symptoms of ADHD, ASD, or schizo-
phrenia and therefore cannot exclude the possibility that
potential intake ofmedication formaternalmental healthhas
led to spurious associations. However, excluding all mothers
who reported they had taken medication for neuropsychiat-
ric problems (ie, depression, anxiety, migraine, or sleeping
problems) didnot changeour results (eTable 10 in the Supple-
ment). We encourage replication of our findings in well-
powered data sets.
Conclusions
Ourfindingssuggest thatseveralearly-life factors linkedtoneu-
rodevelopmental disorders are associated with maternal
genetic liabilities to these disorders, primarily ADHD. There-
fore, to drawconclusions about causality, future studies need
to account for potential genetic confounding and triangulate
evidence from different causally informative approaches. In
addition,motherswith high genetic liability to ADHDmay be
at increased risk for many adverse pregnancy factors.
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